Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT07270016
Status
Recruiting
Apply to this trial

Conditions

  • Continuous Glucose Monitoring
  • Diabetes Mellitus, Type 2
  • Hyperglycemia
  • Lifestyle (Sedentary Behavior and Physical Activity)
  • Physical Inactivity

Eligibility Criteria

Sex
ALL
Age
16 Years - 24 Years
Healthy Volunteers
Not accepted

Interventions

  • Healthmine app — OTHER
    Participants will wear study-provided continuous glucose monitoring device and Fitbit physical activity tracker for 30 consecutive days. During the same period, they will use an investigator-developed smartphone app (Healthmine), which is being developed to pair CGM and Fitbit data. Participants will receive up to one message about health behavior change (e.g., physical activity, nutrition) daily and will be able to use Healthmine to log exercise and dietary intake.

Study Details

The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking participants aged 16-24 years who were diagnosed with type 2 diabetes before age 18. Participants will be asked to fill out surveys about diabetes, physical activity, and diet before and after wearing a CGM for 30 days. At the end of wearing the CGM, participants will complete an interview about their experience.

Key Dates

Start date
Feb 16, 2026
Status verified
Feb 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Single-arm pilot study
    Participants will engage in pilot-testing a novel smartphone app supporting health behavior change and wear a continuous glucose monitoring device and Fitbit physical activity tracker for 30 days. Questionnaires and interviews will be used to gather participant experiences with the app and device wear.

Primary Outcome Measure

Usability of Healthmine app [ Time Frame: 15 days and 30 days after starting study-provided CGM and Healthmine app use ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Children's Hospital of PittsburghPittsburghPennsylvania15224
Mary Ellen Vajravelu, MD, MSHP
[email protected]
412-692-6533
Ana Diaz, RN
[email protected]
412-692-6862

Find similar trials in Pittsburgh, PA

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Children's Hospital of Pittsburgh· Pittsburgh, PA

Related Studies